Florida has become the second U.S. state to ban fluoride in its public water systems, following a controversial trend among Republican-led states. Governor Ron DeSantis signed the legislation on Thursday, calling the addition of fluoride to tap water “forced medication.” The ban takes effect on July 1.
Fluoride, a naturally occurring mineral found in water, soil, and air, has been widely used for decades to prevent cavities and strengthen teeth. About 63% of Americans currently receive fluoridated water, according to the CDC. Public health organizations, including the American Dental Association (ADA), argue that fluoridation significantly improves dental health and poses no proven harm. However, fluoride has faced growing political opposition, especially from figures like DeSantis and Health Secretary Robert F. Kennedy Jr., who link it to health risks such as cancer and reduced cognitive function in children—claims the American Cancer Society says lack strong evidence.
DeSantis, who previously opposed public health mandates during the COVID-19 pandemic, said medical experts “shouldn’t be able to decree how we live our lives,” criticizing what he sees as overreach by health authorities.
Utah became the first state to enact a similar ban in March. Meanwhile, the FDA is currently reviewing the safety of fluoride supplements for children, signaling broader scrutiny of the mineral’s use in public health.
The ADA strongly opposes these moves, urging a thorough review before policy changes are made. President Brett Kessler emphasized the need to “slow down” and fully assess the implications of banning fluoride for national health.
The fluoride debate is intensifying as Republican states challenge long-standing public health practices, raising questions about science, personal choice, and government intervention in health policy.


Russia Intensifies Drone and Bomb Attacks on Ukraine’s Zaporizhzhia, Deepening Civilian Fear
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
U.S. Unseals Charges Against Five Alleged CJNG Leaders, Raises Reward for New Cartel Chief
US Continues Ukraine Patriot Missile Production Talks Despite Trump’s Concerns
China Vows Retaliation Over U.S. Ban on Chinese Robots, Power Inverters
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
US Expands Social Media Vetting to Foreign Journalists Seeking Visas
Bezalel Smotrich Faces Election Battle as Israel’s Far-Right Vote Fractures
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
India Plans Tax Reforms to Boost Foreign Investment and Manufacturing
AI Data Center Boom Faces New Risks as Public Backlash and Policy Scrutiny Grow
US Expects Iran-Oman Hormuz Shipping Deal Soon
3 clinical-grade skincare creams you really shouldn’t buy online
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 



